Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Other Accumulated Expenses: 2022-2024

Historic Other Accumulated Expenses for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $579,000.

  • Orchestra BioMed Holdings' Other Accumulated Expenses rose 43.88% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 43.88%. This contributed to the annual value of $579,000 for FY2024, which is 46.34% down from last year.
  • As of FY2024, Orchestra BioMed Holdings' Other Accumulated Expenses stood at $579,000, which was down 46.34% from $1.1 million recorded in FY2023.
  • Orchestra BioMed Holdings' Other Accumulated Expenses' 5-year high stood at $1.9 million during FY2022, with a 5-year trough of $579,000 in FY2024.
  • In the last 3 years, Orchestra BioMed Holdings' Other Accumulated Expenses had a median value of $1.1 million in 2023 and averaged $1.2 million.
  • Data for Orchestra BioMed Holdings' Other Accumulated Expenses shows a maximum YoY tumbled of 46.34% (in 2024) over the last 5 years.
  • Over the past 3 years, Orchestra BioMed Holdings' Other Accumulated Expenses (Yearly) stood at $1.9 million in 2022, then slumped by 43.00% to $1.1 million in 2023, then slumped by 46.34% to $579,000 in 2024.